Posted by Mark J. Miller on March 8, 2012 11:58 AM
When the news came out of the state of California a year ago that the stuff that makes your cola beverage brown has been linked to cancer, there were a number of consumers that likely didn’t put their change into the vending machine that day.
The amount of that compound (4-methylimidazole, or 4-MEI) in soda would cause the state to need to put warning labels on all of its cans, NPR reports. This, in turn, led to the Washington, D.C.-based Center for Science in the Public Interest (CSPI) to lobby the U.S. Food and Drug Administration to “ban ammonia-sulfite caramel color,” according to NPR. Coke Clear, anyone?
While the cola companies and caramel manufacturers are obviously stating that there is no validity to these claims, the FDA is also chiming in that this could be much ado about not much. In any event, Coca-Cola and PepsiCo, which account for almost 90% of the U.S. soda market, have tweaked their formulas in compliance with the Californian law — averting the need to add a cancer warning label.Continue reading...
Posted by Shirley Brady on February 28, 2012 02:25 PM
As McDonald's promotes its produce suppliers and expands the availability of its lower-calorie Happy Meal kids' combo meals across America, lopping off 20% of the calories if kids eat the packaged apple slices instead of French fries, the fast-food giant is rolling out its first national TV commercial (there's also a Spanish-language version) to promote the healthier option.
As noted here last year, "The new Happy Meal includes both apple slices and a new, smaller serving of French fries, and the beverage choice will include a new fat-free chocolate milk as well as 1% low-fat white milk. The company noted in its announcement that it has offered apple slices as an option in Happy Meals since 2004 — and that 88% of customers know about the option, but only 11% choose the slices."
Posted by Mark J. Miller on February 23, 2012 03:02 PM
Walgreen, the nation’s largest pharmacy, and a slew of independent pharmacies are investing in RxAlly, a “private company that is launching a network involving 20,000 pharmacies focused on better care coordination,” according to the Associated Press.
The idea is for pharmacists to have “a chance to work more with patients to improve care and cut costs.”Continue reading...
Posted by Mark J. Miller on February 9, 2012 10:02 AM
The Food and Drug Administration said in 2009 that it was going to develop standards for what food products can claim to be healthy and what can’t. But there hasn’t been any kind of report as of yet, and Walmart has decided to stop waiting and make one of its own.
A year after pledging to develop a front-of-pack label that would give its customers an easier way to identify healthier food, and a month after a public commitment with First Lady Michelle Obama to putting nutrition front and center in its stores, the nation’s largest food retailer this week unveiled a “Great For You” icon to create a visual system to educate customers.
The Arkansas-based grocery behemoth announced this week that the seal will appear on a variety of house brand food items, with a WalmartGreatforYou.com website supporting the effort.
The green and white seal, "which shows the stylized outline of a human figure with its arms spread toward the sky, is part of a multiyear campaign the world’s largest retailer is undertaking to promote healthier products and fight childhood obesity," the Associated Press reports.
Walmart says it will adapt to whatever the FDA’s regulations are whenever that list actually is produced, but will for now add the icon to products with lower levels of fat, sugar, and artificial additives. Plus, the seal will appear on signage in the fruits and vegetable section of its grocery area.
“It helps customers see very, very quickly what healthier choices are for them,” stated Andrea Thomas, SVP of sustainability for Wal-Mart Stores. More details are in its press release below.Continue reading...
Posted by Mark J. Miller on January 10, 2012 04:54 PM
New York City’s health department does not want fries with that. Or with anything else. In fact, the agency would prefer that its residents don’t bother with fast food and soda altogether — and certainly not in bigger sizes.
A new set of subway posters, printed in both English and Spanish, illustrate “the steady increase in sizes of soda cups and sleeves of French fries against backdrops of unhealthy people, including a diabetic man who is missing most of one leg," as the New York Times notes. The image, as seen at right, draws attention to the amputated leg.
The objective of the city's latest public health campaign is to show how obesity and diabetes have grown as issues at the same time that serving sizes have increased, and their devastating consequences.
“The portion sizes that are marketed are often much more than humans need,” stated Dr. Thomas Farley, the city’s health commissioner, taking a cue from his boss — New York Mayor Michael Bloomberg, whose administration is a veteran of shockvertising to grab the public's attention.Continue reading...
Posted by Mark J. Miller on January 3, 2012 11:49 AM
With the new year comes new resolve to tighten belts, literally, by shedding unwanted pounds accumulated over the holiday (if not earlier). But what about childhood obesity?
A TV and print campaign introduced in August by Children's Healthcare of Atlanta is now being criticized for calling out overweight children to appeal to their adult caregivers, with the goal of shocking them into action and reversing Georgia's title as the American state with the second-hightest rate of childhood obesity. In one commercial, for example, a mother sighs when asked by her son why he's overweight.
Georgia isn't the only state grappling with the obesity epidemic. As America’s waistlines keep growing larger, many states now have laws in place that require restaurants to provide calorie information on its menus. That way, the thinking goes, consumers might stop themselves from chowing down on a 500-calorie double-chocolate brownie. Of course, a calorie count lising on a menu isn't going to deter diners from high-cal choices, but public health advocates argue that consumers have the right to know.Continue reading...
Posted by Mark J. Miller on December 2, 2011 11:31 AM
Big-tobacco companies have been losing battles for years as smokers have been run out of bars and restaurants across America as well as heavy taxes that help fund anti-smoking programs. The anti-tobacco marketing appear to have helped make smoking uncool, with less than 20% of American adults smoking last year, part of a "decades-long decline" as the Wall Street Journal puts it.
So tobacco companies cheered the recent blocking by a U.S. judge blocking the U.S. government's move forcing tobacco companies to put nasty imagery on its packaging to show smokers what might happen to them if they continue inhaling their nicotine.
Now the Associated Press reports that the tobacco companies have another reason to pass around cigars: “States have cut funding for tobacco prevention programs 12 percent this year, to the lowest level since 1999,” according to a new report by the Campaign for Tobacco-Free Kids, the American Cancer Society and other groups.Continue reading...
Posted by Sheila Shayon on November 21, 2011 01:01 PM
As CBS News notes, breast cancer patients are "dismayed" at the FDA's decision to pull Roche's Avastin drug for breast cancer treatment in the U.S.
The blockbuster drug will no longer be available for treatment of advanced breast cancer, a blow to women with the disease who have been lobbying to keep the drug available as an option when all others have failed. The drug remains on the market to treat colon, lung, kidney, and brain cancers.
"I did not come to this decision lightly," stated FDA commissioner Dr. Margaret Hamburg. "Sometimes despite the hopes of investigators, patients, industry and even the FDA itself, the results of rigorous testing can be disappointing."
“We are disappointed with the outcome. We remain committed to the many women with this incurable disease and will continue to provide help through our patient support programs to those who may be facing obstacles to receiving their treatment in the United States,” commented Hal Barron, M.D., chief medical officer and head, Global Product Development at Roche, which makes the cancer drug through its Genentech division. “Despite today’s action, we will start a new Phase III study of Avastin in combination with paclitaxel in previously untreated metastatic breast cancer and will evaluate a potential biomarker that may help identify which people might derive a more substantial benefit from Avastin.” Continue reading...